Dose Discrepancies Between the Physicians' Desk Reference and the Medical Literature, and Their Possible Role in the High Incidence of Dose-Related Adverse Drug Events
Open Access
- 9 April 2001
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 161 (7) , 957-964
- https://doi.org/10.1001/archinte.161.7.957
Abstract
OPINIONS DIFFER regarding the extent of iatrogenic illness secondary to medication reactions, but there is general agreement that this is an important problem. The most recent meta-analysis determined that in 1994 an estimated 106 000 hospital patients had fatal adverse drug events (ADEs), "making these events between the fourth and sixth leading cause of death" in the United States annually.1(p1200) The study also estimated that 2 216 000 hospitalized patients had ADEs that were considered serious, which the study defined as requiring hospitalization, being permanently disabling, or resulting in death. Clearly, even more ADEs occur that do not reach these levels of severity. In a recent editorial, Bates addressed questions about these statistics by stating, "Even if the true incidence of ADEs is somewhat lower than reported by Lazarou et al, it is still high, and much higher than generally recognized."2(p1216) This statement probably represents the general viewpoint.This publication has 69 references indexed in Scilit:
- “Not just a statistic”: the history of USA and UK policy over thrombotic disease and the oral contraceptive pill, 1960s–1970sSocial Science & Medicine, 1999
- Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-Analysis of Prospective StudiesSurvey of Anesthesiology, 1999
- Personal Perspective on Low-dosage Estrogen Therapy for Postmenopausal WomenMenopause, 1999
- Symptom relief and side effects of postmenopausal hormones: results from the postmenopausal estrogen/progestin interventions trialObstetrics & Gynecology, 1998
- Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood PressurePublished by American Medical Association (AMA) ,1997
- JNC guidelines: is the message getting through? Joint National Commission on Detection, Evaluation, and Treatment of High Blood PressurePublished by American Medical Association (AMA) ,1997
- The Physicians' Desk Reference. Problems and possible improvementsArchives of internal medicine (1960), 1996
- Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug DevelopmentThe Journal of Clinical Pharmacology, 1994
- Evaluating Drugs after Their Approval for Clinical UseNew England Journal of Medicine, 1993
- Drug Facts and Comparisons.Annals of Internal Medicine, 1988